首页> 外文期刊>Medicine. >Traditional therapies of Zhuang medicine improve pain and joint dysfunction of patients in rheumatoid arthritis: A protocol for systematic review and meta-analysis
【24h】

Traditional therapies of Zhuang medicine improve pain and joint dysfunction of patients in rheumatoid arthritis: A protocol for systematic review and meta-analysis

机译:庄医药的传统疗法改善了类风湿性关节炎患者的疼痛和关节功能障碍:系统审查和荟萃分析的议定书

获取原文
           

摘要

Background: Rheumatoid arthritis (RA) is a common chronic inflammatory autoimmune disease, which can lead to joint destruction, dysfunction, finally deformity. Currently, Western medicine treats it with disease-modifying antireheumatic drugs, NSAIDs, glucocorticoid, biological agents, etc, which can induce adverse drug reactions. And now, as an important mean of treating RA, Zhuang medicine has been widely used in clinics, and has achieved significant efficacy. Methods and analysis: The following databases will be searched for relevant information before July 2020: PubMed, Embase, Cochrane Library, Web of Science, and China National Knowledge Infrastructure. Major results: levels of C-reactive protein, erythrocyte sedimentation rate, Rheumatoid factor. Secondary results: morning stiffness time, range of motion, arthralgia, joint tenderness index, joint swelling index, total effective rate, adverse event. Data will be collected independently by 2 researchers, and the risk of bias in meta analysis will be evaluated according to “Cochrane Handbook for Systematic Reviews of Interventions”. All data analysis will be conducted using Review Manager V.5.3. and Stata V.12.0. Results: The curative effect and safety of traditional therapies of Zhuang Medicine treatment for RA patients will be evaluated systematically. Conclusion: The systematic review of this study will summarize the currently published evidence of traditional therapies of Zhuang Medicine treatment for RA to further guide its promotion and application. Open Science Framework (OSF) registration number: https://osf.io/c4xv3/ .
机译:背景:类风湿性关节炎(RA)是一种常见的慢性炎症自身免疫疾病,可导致联合破坏,功能障碍,最终畸形。目前,西医用疾病修饰的抗蠕变药物,NSAIDS,糖皮质激素,生物药物等,可以诱导不良药物反应。而现在,作为治疗RA的重要平均值,庄医药已广泛用于诊所,并取得了显着的功效。方法和分析:将在2020年7月2020年7月之前搜索以下数据库:PubMed,Embase,Cochrane图书馆,科学网站和中国国家知识基础设施。主要结果:C反应蛋白,红细胞沉积率,类风湿性因子水平。二次结果:晨刚度时间,运动范围,关节痛,关节柔软指数,联合肿胀指数,总有效率,不良事件。数据将独立收集2个研究人员,并且根据“干预措施的系统审查的Cochrane手册”评估Meta分析中偏差的风险。所有数据分析都将使用Review Manager V.5.3进行。和stata第12.0。结果:RA患者庄医药治疗的传统疗法的疗效和安全性将系统地进行系统。结论:本研究的系​​统审查将总结当前公布的庄医药疗法疗法的证据,以进一步指导其促进和申请。开放式科学框架(OSF)注册号:https://osf.io/c4xv3/。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号